mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.005 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.099 |
0.005 |
mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
0.09 |
0.005 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.005 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.006 |
mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
0.087 |
0.006 |